首页 > 最新文献

Journal of the American Academy of Child and Adolescent Psychiatry最新文献

英文 中文
Editorial: Limitations on the Predictive Validity of the ARFID Diagnosis. 社论:ARFID 诊断预测有效性的局限性。
IF 9.2 1区 医学 Q1 PEDIATRICS Pub Date : 2024-08-15 DOI: 10.1016/j.jaac.2024.08.001
Hana F Zickgraf

Avoidant/restrictive food intake disorder (ARFID) first entered the psychiatric nosology with the 2013 publication of DSM-5. Unlike binge eating disorder (BED), which was also new to DSM-5 but which had first been described by Stunkard in 1959,1,2 ARFID had never been described in the psychiatric literature as a single diagnostic entity. The new diagnosis encompassed clinical constructs that were previously proposed and studied but not described in DSM (ie, causes of "non-organic failure to thrive" including infantile anorexia and post-traumatic feeding disorder,3 and extreme food selectivity in children with autism spectrum disorder4) and the DSM-IV Feeding Disorder of Infancy and Early Childhood (FDIEC).5 The ARFID diagnosis supplanted FDIEC and incorporated earlier descriptions of pediatric feeding problems into a lifespan diagnosis for patients with restrictive eating characterized by food selectivity, poor appetite/lack of interest in eating, or fear of aversive consequences of eating that led to significant weight loss or failure to grow, nutritional deficiency, supplement dependence, and/or psychosocial impairment.

回避型/限制型食物摄入障碍(ARFID)在2013年出版的DSM-5中首次被列入精神科疾病分类。暴饮暴食障碍(BED)也是 DSM-5 中的新术语,但与之不同的是,Stunkard 于 1959 年首次对其进行了描述1,2,而 ARFID 在精神病学文献中从未作为一个单一的诊断实体进行过描述。这一新诊断包含了之前提出并研究过但未在 DSM 中描述的临床概念(即 "非器质性发育不良 "的原因,包括婴儿厌食症和创伤后喂养障碍,3 以及自闭症谱系障碍儿童的极端食物选择性4)和 DSM-IV 中的婴幼儿喂养障碍(FDIEC)。5 ARFID 诊断取代了 FDIEC,并将早先对儿科喂养问题的描述纳入到一个终身诊断中,该诊断针对以食物选择性、食欲差/对进食缺乏兴趣或害怕进食的厌恶性后果为特征的限制性进食患者,进而导致体重显著下降或发育不良、营养缺乏、补充品依赖和/或社会心理损害。
{"title":"Editorial: Limitations on the Predictive Validity of the ARFID Diagnosis.","authors":"Hana F Zickgraf","doi":"10.1016/j.jaac.2024.08.001","DOIUrl":"10.1016/j.jaac.2024.08.001","url":null,"abstract":"<p><p>Avoidant/restrictive food intake disorder (ARFID) first entered the psychiatric nosology with the 2013 publication of DSM-5. Unlike binge eating disorder (BED), which was also new to DSM-5 but which had first been described by Stunkard in 1959,<sup>1</sup><sup>,</sup><sup>2</sup> ARFID had never been described in the psychiatric literature as a single diagnostic entity. The new diagnosis encompassed clinical constructs that were previously proposed and studied but not described in DSM (ie, causes of \"non-organic failure to thrive\" including infantile anorexia and post-traumatic feeding disorder,<sup>3</sup> and extreme food selectivity in children with autism spectrum disorder<sup>4</sup>) and the DSM-IV Feeding Disorder of Infancy and Early Childhood (FDIEC).<sup>5</sup> The ARFID diagnosis supplanted FDIEC and incorporated earlier descriptions of pediatric feeding problems into a lifespan diagnosis for patients with restrictive eating characterized by food selectivity, poor appetite/lack of interest in eating, or fear of aversive consequences of eating that led to significant weight loss or failure to grow, nutritional deficiency, supplement dependence, and/or psychosocial impairment.</p>","PeriodicalId":17186,"journal":{"name":"Journal of the American Academy of Child and Adolescent Psychiatry","volume":null,"pages":null},"PeriodicalIF":9.2,"publicationDate":"2024-08-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141995961","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Editorial: Interpersonal Racial-Ethnic Discrimination and Psychopathology in the ABCD Cohort. 社论:ABCD 群体中的人际种族-民族歧视和精神病理学。
IF 9.2 1区 医学 Q1 PEDIATRICS Pub Date : 2024-08-15 DOI: 10.1016/j.jaac.2024.08.002
Kara S Bagot

Discrimination and structural factors that promote discrimination and sociocultural inequities are social determinants of health that contribute to poorer health outcomes among minoritized youth. Discrimination consists of institutional or individual-level biases leading to disparate and unequitable access to resources. If individuals are aware of these experiences and their impact on one's own ability to access resources or opportunities, individuals may self-report these occurrences. Experiences of discrimination, and one's personal experience of discrimination at individual, social, and/or institutional levels have been shown to contribute to worse psychiatric outcomes through the emergence of and increased severity of psychopathology, reduced access to treatment, decreased likelihood of active treatment seeking, and poorer treatment retention.1,2 For youth, early and repeated exposures to discrimination, and perception of discrimination, may contribute to health disparities in psychopathology in adolescence, young adulthood, and beyond. Our understanding of protective factors and primary and secondary prevention strategies is limited, given the lack of systematic research on early and persistent exposure to discrimination on developmental outcomes in minoritized youth. Large longitudinal research studies with representative heterogeneous samples may allow for the study of these relationships.

歧视以及助长歧视和社会文化不平等的结构性因素是健康的社会决定因素,导致少数群体青年的健康状况较差。歧视包括机构或个人层面的偏见,导致在获取资源方面的差异和不公平。如果个人意识到这些经历及其对自己获取资源或机会的能力的影响,个人可能会自我报告这些事件。事实证明,歧视经历以及个人在个人、社会和/或机构层面上遭受歧视的经历,会导致精神病理的出现和严重程度的增加、治疗机会的减少、积极寻求治疗的可能性降低以及治疗效果的降低,从而导致更糟糕的精神疾病结果。我们对保护性因素以及一级和二级预防策略的了解是有限的,因为我们缺乏对少数族裔青少年早期和持续遭受歧视对发育结果影响的系统研究。利用具有代表性的异质样本进行大型纵向研究,可以对这些关系进行研究。
{"title":"Editorial: Interpersonal Racial-Ethnic Discrimination and Psychopathology in the ABCD Cohort.","authors":"Kara S Bagot","doi":"10.1016/j.jaac.2024.08.002","DOIUrl":"10.1016/j.jaac.2024.08.002","url":null,"abstract":"<p><p>Discrimination and structural factors that promote discrimination and sociocultural inequities are social determinants of health that contribute to poorer health outcomes among minoritized youth. Discrimination consists of institutional or individual-level biases leading to disparate and unequitable access to resources. If individuals are aware of these experiences and their impact on one's own ability to access resources or opportunities, individuals may self-report these occurrences. Experiences of discrimination, and one's personal experience of discrimination at individual, social, and/or institutional levels have been shown to contribute to worse psychiatric outcomes through the emergence of and increased severity of psychopathology, reduced access to treatment, decreased likelihood of active treatment seeking, and poorer treatment retention.<sup>1</sup><sup>,</sup><sup>2</sup> For youth, early and repeated exposures to discrimination, and perception of discrimination, may contribute to health disparities in psychopathology in adolescence, young adulthood, and beyond. Our understanding of protective factors and primary and secondary prevention strategies is limited, given the lack of systematic research on early and persistent exposure to discrimination on developmental outcomes in minoritized youth. Large longitudinal research studies with representative heterogeneous samples may allow for the study of these relationships.</p>","PeriodicalId":17186,"journal":{"name":"Journal of the American Academy of Child and Adolescent Psychiatry","volume":null,"pages":null},"PeriodicalIF":9.2,"publicationDate":"2024-08-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141995960","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Embodying AACAP's Presidential Initiative to Combat Digital Racism in Youth. 体现 AACAP 打击青少年数字种族主义的总统倡议。
IF 9.2 1区 医学 Q1 PEDIATRICS Pub Date : 2024-08-14 DOI: 10.1016/j.jaac.2024.07.922
Sahit N Menon, Zamaan Qureshi, Alison Rice, Barbara Robles-Ramamurthy

In her presidential initiative, AACAP President Dr. Tami Benton outlined her vision for the dynamic role of child and adolescent psychiatrists and their respective communities, encouraging them to transcend traditional clinical roles and become public health advocates by "Bringing the Village to the Children." This message emphasizes the capacity of child and adolescent psychiatrists to reach beyond clinical silos and identify partnerships across a variety of disciplines to improve child mental health. This commentary summarizes concrete opportunities for child and adolescent psychiatrists and trainees to advocate for social media safety that protects the rights of racially minoritized children and adolescents by aligning with the presidential initiative.

AACAP 主席塔米-本顿博士(Dr. Tami Benton)在其主席倡议中概述了她对儿童和青少年精神科医生及其各自社区的动态角色的愿景,鼓励他们超越传统的临床角色,通过 "将村庄带到儿童身边 "来成为公共卫生的倡导者。这一信息强调了儿童青少年精神科医生有能力超越临床孤岛,在不同学科间建立合作关系,以改善儿童心理健康。本评论总结了儿童青少年精神科医生和受训人员倡导社交媒体安全的具体机会,通过与总统倡议保持一致来保护少数种族儿童和青少年的权利。
{"title":"Embodying AACAP's Presidential Initiative to Combat Digital Racism in Youth.","authors":"Sahit N Menon, Zamaan Qureshi, Alison Rice, Barbara Robles-Ramamurthy","doi":"10.1016/j.jaac.2024.07.922","DOIUrl":"10.1016/j.jaac.2024.07.922","url":null,"abstract":"<p><p>In her presidential initiative, AACAP President Dr. Tami Benton outlined her vision for the dynamic role of child and adolescent psychiatrists and their respective communities, encouraging them to transcend traditional clinical roles and become public health advocates by \"Bringing the Village to the Children.\" This message emphasizes the capacity of child and adolescent psychiatrists to reach beyond clinical silos and identify partnerships across a variety of disciplines to improve child mental health. This commentary summarizes concrete opportunities for child and adolescent psychiatrists and trainees to advocate for social media safety that protects the rights of racially minoritized children and adolescents by aligning with the presidential initiative.</p>","PeriodicalId":17186,"journal":{"name":"Journal of the American Academy of Child and Adolescent Psychiatry","volume":null,"pages":null},"PeriodicalIF":9.2,"publicationDate":"2024-08-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141995963","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Addressing Inequity in Mental Health Provision for Children and Adolescents With Developmental Language Disorder. 解决为患有发育性语言障碍的儿童和青少年提供心理健康服务方面的不平等问题。
IF 9.2 1区 医学 Q1 PEDIATRICS Pub Date : 2024-08-14 DOI: 10.1016/j.jaac.2024.07.923
Sarah Griffiths, Shaun Kok Yew Goh, Mark E Boyes, Elizabeth Hill, Essi Viding, Courtenay Norbury

The above case study is fictional, but Oliver's difficulties are representative of the experiences of many young people with a language disorder. Unfortunately, integrated mental health and speech-language therapy services are rare, and available research to inform evidence-based mental health intervention for this population is lacking. Children and adolescents with DLD have a 1.8- to 2.3-fold increased risk of mental health conditions compared with peers,1 and 45% to 64% of adolescents referred to mental health services have diagnosed or undiagnosed language disorder.2 Mental health assessments and psychological treatments are verbally mediated, making them difficult for youth such as Oliver to access.3 To address this inequality in mental health provision, we need increased understanding and awareness of language disorders and how they can affect mental health, novel language interventions aimed to prevent mental health problems in youth with language disorders, and adaptations to existing mental health treatments to make them suitable for youth with language disorders.

奥利弗是一名 12 岁的男孩,因拒绝上学而被转介到儿童和青少年心理健康服务机构。奥利弗在学校一直很努力。他经常因为上课不听讲而惹麻烦,当他在课间休息时想和同学们一起玩游戏时,同学们经常嘲笑他。有时他会发脾气,但当老师问他发生了什么事时,他又无法解释自己的想法。最近,奥利弗变得焦虑、孤僻,拒绝上学。儿童和青少年心理健康服务机构为奥利弗提供了谈话疗法,作为焦虑症的一线治疗方法。然而,奥利弗在治疗中表现得很不积极;他似乎不听治疗师在说什么,也很少回话。奥利弗的治疗师将他介绍给了同一组的语言病理学家,后者诊断奥利弗患有发育性语言障碍 (DLD)。现在,两位治疗师正与学校合作,为奥利弗的焦虑和语言障碍提供支持。
{"title":"Addressing Inequity in Mental Health Provision for Children and Adolescents With Developmental Language Disorder.","authors":"Sarah Griffiths, Shaun Kok Yew Goh, Mark E Boyes, Elizabeth Hill, Essi Viding, Courtenay Norbury","doi":"10.1016/j.jaac.2024.07.923","DOIUrl":"10.1016/j.jaac.2024.07.923","url":null,"abstract":"<p><p>The above case study is fictional, but Oliver's difficulties are representative of the experiences of many young people with a language disorder. Unfortunately, integrated mental health and speech-language therapy services are rare, and available research to inform evidence-based mental health intervention for this population is lacking. Children and adolescents with DLD have a 1.8- to 2.3-fold increased risk of mental health conditions compared with peers,<sup>1</sup> and 45% to 64% of adolescents referred to mental health services have diagnosed or undiagnosed language disorder.<sup>2</sup> Mental health assessments and psychological treatments are verbally mediated, making them difficult for youth such as Oliver to access.<sup>3</sup> To address this inequality in mental health provision, we need increased understanding and awareness of language disorders and how they can affect mental health, novel language interventions aimed to prevent mental health problems in youth with language disorders, and adaptations to existing mental health treatments to make them suitable for youth with language disorders.</p>","PeriodicalId":17186,"journal":{"name":"Journal of the American Academy of Child and Adolescent Psychiatry","volume":null,"pages":null},"PeriodicalIF":9.2,"publicationDate":"2024-08-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141995958","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Systematic Review: Measurement Properties of Patient-Reported Outcome Measures Used to Measure Depression Symptom Severity in Adolescents With Depression. 系统性综述:用于测量青少年抑郁症患者抑郁症状严重程度的 "患者报告结果测量法 "的测量特性。
IF 9.2 1区 医学 Q1 PEDIATRICS Pub Date : 2024-08-12 DOI: 10.1016/j.jaac.2024.06.011
Suneeta Monga, Sorina Andrei, Rebecka C Quinn, Valeria Khudiakova, Riddhi Desai, Abiramy Srirangan, Sneha Patel, Peter Szatmari, Nancy J Butcher, Karolin R Krause, Darren B Courtney, Martin Offringa, Ellen B M Elsman

Objective: To systematically evaluate the measurement properties of 12 patient-reported outcome measures (PROMs) used to measure depression symptom severity in adolescents with depression. Depression symptom severity was chosen as the outcome of focus given its importance as an outcome to measure in adolescents with depression across clinical trials and/or care.

Method: MEDLINE, PsycInfo, Scopus, CINAHL, and Web of Science were searched from year of inception up to December 7th, 2023. Study appraisal (i.e., risk of bias), evaluation of measurement properties, and evidence synthesis followed the COnsensus-based Standards for the selection of health Measurement INstruments (COSMIN) guidelines. Included studies evaluated at least one of nine measurement properties as detailed in the COSMIN taxonomy within a reported sample or subgroup of youth 12-24 years, with at least 40% meeting criteria for any depressive disorder.

Results: Of the 15,560 records identified, 31 studies for seven PROMs were included in the COSMIN appraisal. Although several PROMs have the potential to accurately measure depression symptom severity in adolescents with depression, at this time none of the PROMs can be recommended for use without further evaluative work. High-quality evidence was generally lacking, largely due to few or inconsistent findings, small sample sizes, and other methodological concerns.

Conclusion: This systematic review of the measurement properties of 12 PROMs used to measure depression symptom severity in adolescents with depression found that none of the PROMs can be recommended for use until further evaluative work is conducted. Clinicians and researchers should proceed with caution when using these PROMs.

目的系统评估用于测量青少年抑郁症患者抑郁症状严重程度的12种患者报告结果测量法(PROMs)的测量特性。鉴于抑郁症状严重程度是衡量青少年抑郁症患者临床试验和/或护理的重要结果,因此选择抑郁症状严重程度作为重点结果:方法:检索了 MEDLINE、PsycInfo、Scopus、CINAHL 和 Web of Science,检索时间从开始检索的年份起至 2023 年 12 月 7 日。研究评估(即偏倚风险)、测量属性评估和证据综合均遵循基于共识的健康测量工具选择标准(COSMIN)指南。所纳入的研究至少评估了 COSMIN 分类法中详细列出的九种测量特性中的一种,研究对象为已报告的 12-24 岁青少年样本或亚组,其中至少有 40% 符合任何抑郁障碍的标准:在已确认的 15,560 条记录中,有 31 项针对 7 个 PROM 的研究被纳入 COSMIN 评估。尽管有几项 PROMs 有可能准确测量患有抑郁症的青少年的抑郁症状严重程度,但在没有进一步评估工作的情况下,目前还不能推荐使用任何 PROMs。总体而言,缺乏高质量的证据,这主要是由于研究结果较少或不一致、样本量较小以及其他方法学方面的问题:本研究对用于测量青少年抑郁症状严重程度的 12 个 PROM 的测量属性进行了系统性回顾,结果发现,在开展进一步评估工作之前,没有一个 PROM 可以推荐使用。临床医生和研究人员在使用这些 PROM 时应谨慎行事。
{"title":"Systematic Review: Measurement Properties of Patient-Reported Outcome Measures Used to Measure Depression Symptom Severity in Adolescents With Depression.","authors":"Suneeta Monga, Sorina Andrei, Rebecka C Quinn, Valeria Khudiakova, Riddhi Desai, Abiramy Srirangan, Sneha Patel, Peter Szatmari, Nancy J Butcher, Karolin R Krause, Darren B Courtney, Martin Offringa, Ellen B M Elsman","doi":"10.1016/j.jaac.2024.06.011","DOIUrl":"https://doi.org/10.1016/j.jaac.2024.06.011","url":null,"abstract":"<p><strong>Objective: </strong>To systematically evaluate the measurement properties of 12 patient-reported outcome measures (PROMs) used to measure depression symptom severity in adolescents with depression. Depression symptom severity was chosen as the outcome of focus given its importance as an outcome to measure in adolescents with depression across clinical trials and/or care.</p><p><strong>Method: </strong>MEDLINE, PsycInfo, Scopus, CINAHL, and Web of Science were searched from year of inception up to December 7<sup>th</sup>, 2023. Study appraisal (i.e., risk of bias), evaluation of measurement properties, and evidence synthesis followed the COnsensus-based Standards for the selection of health Measurement INstruments (COSMIN) guidelines. Included studies evaluated at least one of nine measurement properties as detailed in the COSMIN taxonomy within a reported sample or subgroup of youth 12-24 years, with at least 40% meeting criteria for any depressive disorder.</p><p><strong>Results: </strong>Of the 15,560 records identified, 31 studies for seven PROMs were included in the COSMIN appraisal. Although several PROMs have the potential to accurately measure depression symptom severity in adolescents with depression, at this time none of the PROMs can be recommended for use without further evaluative work. High-quality evidence was generally lacking, largely due to few or inconsistent findings, small sample sizes, and other methodological concerns.</p><p><strong>Conclusion: </strong>This systematic review of the measurement properties of 12 PROMs used to measure depression symptom severity in adolescents with depression found that none of the PROMs can be recommended for use until further evaluative work is conducted. Clinicians and researchers should proceed with caution when using these PROMs.</p>","PeriodicalId":17186,"journal":{"name":"Journal of the American Academy of Child and Adolescent Psychiatry","volume":null,"pages":null},"PeriodicalIF":9.2,"publicationDate":"2024-08-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141995964","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Systematic Review and Network Meta-Analysis: Efficacy and Safety of Antipsychotics vs Antiepileptics or Lithium for Acute Mania in Children and Adolescents. 系统综述和网络元分析:抗精神病药与抗癫痫药或锂治疗儿童和青少年急性躁狂症的疗效和安全性对比。
IF 9.2 1区 医学 Q1 PEDIATRICS Pub Date : 2024-08-09 DOI: 10.1016/j.jaac.2024.07.920
Giovanni Vita, Viktor B Nöhles, Giovanni Ostuzzi, Corrado Barbui, Federico Tedeschi, Fabiola H Heuer, Amanda Keller, Melissa P DelBello, Jeffrey A Welge, Thomas J Blom, Robert A Kowatch, Christoph U Correll
<p><strong>Objective: </strong>To compare second-generation antipsychotics (SGAs) and mood stabilizers (MSs) in youth with a bipolar disorder type I (BD-I) manic/mixed episode.</p><p><strong>Method: </strong>A systematic PubMed/Embase/PsycInfo literature search until December 31, 2023, for randomized trials of SGAs or MSs in patients ≤18 years of age with BD-I manic/mixed episode was conducted. The study included a network meta-analysis comparing treatments regarding mania symptoms and mania response (co-primary outcomes), and secondary efficacy and tolerability outcomes.</p><p><strong>Results: </strong>Eighteen studies (n = 2844, mean age = 11.74, female participants = 48.0%, mean study duration = 5.4 weeks) comparing 6 SGAs (aripiprazole, asenapine, olanzapine, quetiapine, risperidone, and ziprasidone) and 4 MSs (lithium, oxcarbazepine, topiramate, and valproate) were meta-analyzed. All 6 SGAs outperformed placebo in reducing manic symptomatology, including risperidone (standardized mean difference [SMD] = -1.18, 95% CI = -0.92, -1.45, Confidence in Network Meta-Analysis [CINeMA] = moderate confidence), olanzapine (SMD = -0.77, 95% CI = -0.36, -1.18, low confidence), aripiprazole (SMD = -0.67, 95% CI = -0.33, -1.01, moderate confidence), quetiapine (SMD = -0.60, 95% CI = -0.32, -0.87, high confidence), asenapine (SMD = -0.54, 95% CI = -0.19, -0.89, moderate confidence), and ziprasidone (SMD = -0.43, 95% CI = -0.17, 0.70, low confidence), whereas no mood stabilizer outperformed placebo. Concerning mania response, risperidone (Risk ratio [RR] = 2.58, 95% CI = 1.88, 3.54, low confidence), olanzapine (RR = 2.42, 95% CI = 1.33, 3.54, very low confidence), aripiprazole (RR = 2.05, 95% CI = 1.44, 2.92, low confidence), quetiapine (RR = 1.89, 95% CI = 1.45n 2.47, moderate confidence), asenapine (RR = 1.81, 95% CI = 1.28, 2.55, very low confidence) and lithium (RR = 1.35, 95% CI = 1.00, 1.83, p = .049, very low confidence) outperformed placebo, without superiority of other MSs vs placebo. Individually, risperidone was more efficacious in reducing manic symptomatology than all other comparators, except olanzapine and topiramate, yet with low/very low confidence, and was associated with increased prolactin and glucose. Pooled together, SGAs outperformed both placebo and MSs for mania symptom reduction (SMD = -0.68, 95% CI = -0.86, -0.51 and SMD = -0.61, 95% CI = -0.82, -0.40, moderate confidence), and mania response (RR = 1.85, 95% CI = 1.53, 2.24 and RR = 1.65, 95% CI = 1.33, 2.04, moderate confidence) without differences between MSs and placebo. There were no significant treatment-placebo differences for all-cause discontinuation, whereas lithium, ziprasidone, and oxcarbazepine were associated with more adverse event-related drop-outs than placebo. Most SGAs were associated with more sedation, weight gain, and metabolic issues vs placebo and MSs.</p><p><strong>Conclusion: </strong>SGAs were more efficacious than placebo and MSs in treating acute mania s
目的:比较第二代抗精神病药物(SGAs)和情绪稳定剂(MSs比较第二代抗精神病药(SGAs)和情绪稳定剂(MSs)对躁狂/混合型双相情感障碍(BD-I)青年患者的治疗效果:方法:系统检索PubMed/Embase/PsycInfo文献,检索期至2023年12月31日,检索针对18岁以下BD-I躁狂/混合发作患者的SGAs或MSs随机试验。网络荟萃分析比较了有关躁狂症状和躁狂反应(共同主要结果)以及次要疗效和耐受性结果的治疗方法:18项研究(n=2844,平均年龄=11.74,女性=48.0%,平均研究时间=5.4周)比较了6种SGA(阿立哌唑、阿塞那平、奥氮平、喹硫平、利培酮、齐拉西酮)和4种MS(锂、奥卡西平、托吡酯、丙戊酸钠)。所有六种SGA在减少躁狂症状方面的表现均优于安慰剂,包括利培酮(SMD=-1.18,95%CI=-0.92;-1.45,CINeMA=中等置信度)、奥氮平(SMD=-0.77,95%CI=-0.36;-1.18,低置信度)、阿立哌唑(SMD=-0.67,95%CI=-0.33;-1.01,中等置信度)、喹硫平(SMD=-0.60,95%CI=-0.32,-0.87,高置信度)、阿塞那平(SMD=-0.54,95%CI=-0.19; -0.89,中等置信度)和齐拉西酮(SMD=-0.43,95%CI=-0.17-0.70,低置信度),而没有一种情绪稳定剂的表现优于安慰剂。47,中等置信度)、阿塞那平(RR=1.81,95%CI=1.28-2.55,极低置信度)和锂(RR=1.35,95%CI=1.00;1.83,P值=0.049,极低置信度)的疗效优于安慰剂,其他MSs与安慰剂相比没有优势。单独来看,利培酮在减轻躁狂症状方面的疗效优于除奥氮平和托吡酯以外的所有其他比较药,但可信度较低/非常低,且与催乳素和血糖升高有关。汇总结果显示,SGAs在减少躁狂症状(SMD=-0.68,95%CI=-0.86;-0.51和SMD=-0.61,95%CI=-0.82;-0.40,中等置信度)和躁狂反应(RR=1.85,95%CI=1.53;2.24和RR=1.65,95%CI=1.33-2.04,中等置信度)方面优于安慰剂和MSs,但MSs与安慰剂之间无差异。在全因停药方面,治疗与安慰剂之间没有明显差异,而与安慰剂相比,锂、齐拉西酮和奥卡西平与不良事件相关的停药率更高。与安慰剂和MS相比,大多数SGAs与更多的镇静、体重增加和代谢问题有关:结论:在治疗急性躁狂症状方面,SGAs 比安慰剂和 MSs 更有效,但在使用时必须仔细权衡其重要的副作用。
{"title":"Systematic Review and Network Meta-Analysis: Efficacy and Safety of Antipsychotics vs Antiepileptics or Lithium for Acute Mania in Children and Adolescents.","authors":"Giovanni Vita, Viktor B Nöhles, Giovanni Ostuzzi, Corrado Barbui, Federico Tedeschi, Fabiola H Heuer, Amanda Keller, Melissa P DelBello, Jeffrey A Welge, Thomas J Blom, Robert A Kowatch, Christoph U Correll","doi":"10.1016/j.jaac.2024.07.920","DOIUrl":"10.1016/j.jaac.2024.07.920","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Objective: &lt;/strong&gt;To compare second-generation antipsychotics (SGAs) and mood stabilizers (MSs) in youth with a bipolar disorder type I (BD-I) manic/mixed episode.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Method: &lt;/strong&gt;A systematic PubMed/Embase/PsycInfo literature search until December 31, 2023, for randomized trials of SGAs or MSs in patients ≤18 years of age with BD-I manic/mixed episode was conducted. The study included a network meta-analysis comparing treatments regarding mania symptoms and mania response (co-primary outcomes), and secondary efficacy and tolerability outcomes.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;Eighteen studies (n = 2844, mean age = 11.74, female participants = 48.0%, mean study duration = 5.4 weeks) comparing 6 SGAs (aripiprazole, asenapine, olanzapine, quetiapine, risperidone, and ziprasidone) and 4 MSs (lithium, oxcarbazepine, topiramate, and valproate) were meta-analyzed. All 6 SGAs outperformed placebo in reducing manic symptomatology, including risperidone (standardized mean difference [SMD] = -1.18, 95% CI = -0.92, -1.45, Confidence in Network Meta-Analysis [CINeMA] = moderate confidence), olanzapine (SMD = -0.77, 95% CI = -0.36, -1.18, low confidence), aripiprazole (SMD = -0.67, 95% CI = -0.33, -1.01, moderate confidence), quetiapine (SMD = -0.60, 95% CI = -0.32, -0.87, high confidence), asenapine (SMD = -0.54, 95% CI = -0.19, -0.89, moderate confidence), and ziprasidone (SMD = -0.43, 95% CI = -0.17, 0.70, low confidence), whereas no mood stabilizer outperformed placebo. Concerning mania response, risperidone (Risk ratio [RR] = 2.58, 95% CI = 1.88, 3.54, low confidence), olanzapine (RR = 2.42, 95% CI = 1.33, 3.54, very low confidence), aripiprazole (RR = 2.05, 95% CI = 1.44, 2.92, low confidence), quetiapine (RR = 1.89, 95% CI = 1.45n 2.47, moderate confidence), asenapine (RR = 1.81, 95% CI = 1.28, 2.55, very low confidence) and lithium (RR = 1.35, 95% CI = 1.00, 1.83, p = .049, very low confidence) outperformed placebo, without superiority of other MSs vs placebo. Individually, risperidone was more efficacious in reducing manic symptomatology than all other comparators, except olanzapine and topiramate, yet with low/very low confidence, and was associated with increased prolactin and glucose. Pooled together, SGAs outperformed both placebo and MSs for mania symptom reduction (SMD = -0.68, 95% CI = -0.86, -0.51 and SMD = -0.61, 95% CI = -0.82, -0.40, moderate confidence), and mania response (RR = 1.85, 95% CI = 1.53, 2.24 and RR = 1.65, 95% CI = 1.33, 2.04, moderate confidence) without differences between MSs and placebo. There were no significant treatment-placebo differences for all-cause discontinuation, whereas lithium, ziprasidone, and oxcarbazepine were associated with more adverse event-related drop-outs than placebo. Most SGAs were associated with more sedation, weight gain, and metabolic issues vs placebo and MSs.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusion: &lt;/strong&gt;SGAs were more efficacious than placebo and MSs in treating acute mania s","PeriodicalId":17186,"journal":{"name":"Journal of the American Academy of Child and Adolescent Psychiatry","volume":null,"pages":null},"PeriodicalIF":9.2,"publicationDate":"2024-08-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141917013","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Characteristics Associated With Mental Health Treatment Prior to Suicide Among Youth in the United States. 美国青少年自杀前接受心理健康治疗的相关特征。
IF 9.2 1区 医学 Q1 PEDIATRICS Pub Date : 2024-08-09 DOI: 10.1016/j.jaac.2024.07.921
Cynthia A Fontanella, Xueting Xia, John V Campo, Danielle L Steelesmith, Jeffrey A Bridge, Donna A Ruch

Objective: To examine individual and contextual characteristics associated with receipt of mental health treatment prior to youth suicide.

Method: Data from the US National Violent Death Reporting System, Area Health Resource File, and Social Vulnerability Index were used to examine characteristics associated with receipt of mental health treatment within 2 months before death among youth suicide decedents aged 5 to 17 years from 2013 to 2020 (N = 6,229). The association between individual (demographic, precipitating circumstances, and clinical characteristics) and contextual-level variables (county health resources, Social Vulnerability Index) and mental health service use was modeled using logistic regression.

Results: Mental health treatment was received by 31.6% of youth suicide decedents (n = 1,967) in the 2 months before suicide. Male individuals and youth from all racial and ethnic minority groups were less likely to receive mental health treatment in the 2 months prior to suicide, as were youth residing in non-metropolitan counties and living in counties characterized by high compared to low levels of social vulnerability. A history of family problems, a recent crisis, criminal/legal problems, and suicidal thoughts and attempts were associated with increased odds of receiving mental health services.

Conclusion: Youth suicide decedents who were male, members of a racial or ethnic minority group, and residing in counties that are non-metropolitan and/or socially disadvantaged were less likely to have received mental health services in the months prior to death. Suicide prevention efforts that focus on improving access to care are essential for these vulnerable populations at risk for suicide.

目的:研究与青少年自杀前接受心理健康治疗相关的个体特征和环境特征:研究与青少年自杀前接受心理健康治疗相关的个体特征和环境特征:方法:利用美国国家暴力死亡报告系统、地区卫生资源档案和社会脆弱性指数的数据,研究2013年至2020年期间5至17岁青少年自杀死者(N=6229)在死前两个月内接受心理健康治疗的相关特征。采用逻辑回归法对个体(人口统计学特征、诱发因素和临床特征)和背景水平(县级卫生资源、社会脆弱性指数)变量与心理健康服务使用之间的关系进行了建模:31.6%的自杀身亡青少年(人数=1967)在自杀前两个月接受了心理健康治疗。在自杀前的两个月内,男性和来自所有少数种族和民族群体的青少年接受心理健康治疗的可能性较低,居住在非都会区的青少年和居住在社会脆弱性水平较高而非较低的地区的青少年也是如此。家庭问题史、近期危机、犯罪/法律问题、自杀想法和自杀未遂与接受心理健康服务的几率增加有关:结论:男性、少数种族或民族成员、居住在非大都市和/或社会弱势地区的青少年自杀死者在死前几个月接受心理健康服务的可能性较低。对于这些有自杀风险的弱势群体来说,预防自杀的重点在于改善他们获得医疗服务的机会。
{"title":"Characteristics Associated With Mental Health Treatment Prior to Suicide Among Youth in the United States.","authors":"Cynthia A Fontanella, Xueting Xia, John V Campo, Danielle L Steelesmith, Jeffrey A Bridge, Donna A Ruch","doi":"10.1016/j.jaac.2024.07.921","DOIUrl":"10.1016/j.jaac.2024.07.921","url":null,"abstract":"<p><strong>Objective: </strong>To examine individual and contextual characteristics associated with receipt of mental health treatment prior to youth suicide.</p><p><strong>Method: </strong>Data from the US National Violent Death Reporting System, Area Health Resource File, and Social Vulnerability Index were used to examine characteristics associated with receipt of mental health treatment within 2 months before death among youth suicide decedents aged 5 to 17 years from 2013 to 2020 (N = 6,229). The association between individual (demographic, precipitating circumstances, and clinical characteristics) and contextual-level variables (county health resources, Social Vulnerability Index) and mental health service use was modeled using logistic regression.</p><p><strong>Results: </strong>Mental health treatment was received by 31.6% of youth suicide decedents (n = 1,967) in the 2 months before suicide. Male individuals and youth from all racial and ethnic minority groups were less likely to receive mental health treatment in the 2 months prior to suicide, as were youth residing in non-metropolitan counties and living in counties characterized by high compared to low levels of social vulnerability. A history of family problems, a recent crisis, criminal/legal problems, and suicidal thoughts and attempts were associated with increased odds of receiving mental health services.</p><p><strong>Conclusion: </strong>Youth suicide decedents who were male, members of a racial or ethnic minority group, and residing in counties that are non-metropolitan and/or socially disadvantaged were less likely to have received mental health services in the months prior to death. Suicide prevention efforts that focus on improving access to care are essential for these vulnerable populations at risk for suicide.</p>","PeriodicalId":17186,"journal":{"name":"Journal of the American Academy of Child and Adolescent Psychiatry","volume":null,"pages":null},"PeriodicalIF":9.2,"publicationDate":"2024-08-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141917012","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Sexual Orientation Differences in Age of First Treatment for a Mental Health Diagnosis: A Population-Based Study of Childhood and Adolescence. 首次接受心理健康诊断治疗年龄的性取向差异:基于人口的儿童和青少年研究。
IF 9.2 1区 医学 Q1 PEDIATRICS Pub Date : 2024-08-02 DOI: 10.1016/j.jaac.2024.07.916
Richard Bränström, John E Pachankis

Objective: The aim of the current study was to identify the age at which sexual orientation disparity in mental health diagnoses can be first identified, as well as gender and sexual identity subgroup differences in such treatment, in a population-based sample.

Method: Young people aged 16 to 25 (N = 10,406) participating in the probability-based Swedish National Public Health Survey in 2018 were included. This sample was linked to physician-assessed mental health care treatment history data starting when all participants were 8 years old using national health care registries.

Results: Participants reporting a sexual minority identity in adolescence and young adulthood were more than 3 times as likely to have been treated for an internalizing disorder diagnosis (eg, depression, anxiety) and more than twice as likely to have been treated for a neurodevelopmental disorder diagnosis during childhood than participants reporting a heterosexual identity. Sexual minority participants overall and women in particular were more likely to have been treated for an internalizing disorder diagnosis at an early age compared with heterosexual participants, with this disparity starting at age 13. The sexual orientation disparity in likelihood of treatment for a neurodevelopmental disorder diagnosis was particularly elevated among bisexual/pansexual women with this disparity starting in early/middle adolescence.

Conclusion: This population-based study linked to physician-assessed mental health diagnoses during childhood and adolescence identifies the age at which sexual orientation differences in treatment for common mental disorders emerge. The early emergence of this disparity suggests a potential benefit of interventions that facilitate social belonging for all youth.

研究目的本研究的目的是在基于人口的样本中,确定首次发现精神健康诊断中性取向差异的年龄,以及此类治疗中的性别和性身份亚群差异:研究纳入了参加2018年基于概率的瑞典全国公共卫生调查的16至25岁的个人(n=10365)。该样本与医生评估的心理健康护理治疗史数据相关联,这些数据从样本中所有人8岁开始使用国家医疗保健登记册:与那些报告自己是异性恋者的人相比,在青春期和青年期报告自己是性少数群体的人接受内化障碍诊断(如抑郁、焦虑)治疗的可能性是后者的三倍多,在童年时期接受神经发育障碍诊断治疗的可能性是后者的两倍多。总体而言,与异性恋者相比,性少数群体,尤其是女性,更有可能在幼年时期就因内化障碍诊断而接受治疗,这种差异从 13 岁就开始了。双性恋/跨性别女性因神经发育障碍诊断而接受治疗的性取向差异尤其明显,这种差异从青春期早期/中期就开始了:这项首次基于人群的研究与医生评估的儿童和青少年时期心理健康诊断相关联,确定了常见精神障碍治疗中出现性取向差异的年龄。这种差异的早期出现表明,促进所有青少年社会归属感的干预措施具有潜在的益处。
{"title":"Sexual Orientation Differences in Age of First Treatment for a Mental Health Diagnosis: A Population-Based Study of Childhood and Adolescence.","authors":"Richard Bränström, John E Pachankis","doi":"10.1016/j.jaac.2024.07.916","DOIUrl":"10.1016/j.jaac.2024.07.916","url":null,"abstract":"<p><strong>Objective: </strong>The aim of the current study was to identify the age at which sexual orientation disparity in mental health diagnoses can be first identified, as well as gender and sexual identity subgroup differences in such treatment, in a population-based sample.</p><p><strong>Method: </strong>Young people aged 16 to 25 (N = 10,406) participating in the probability-based Swedish National Public Health Survey in 2018 were included. This sample was linked to physician-assessed mental health care treatment history data starting when all participants were 8 years old using national health care registries.</p><p><strong>Results: </strong>Participants reporting a sexual minority identity in adolescence and young adulthood were more than 3 times as likely to have been treated for an internalizing disorder diagnosis (eg, depression, anxiety) and more than twice as likely to have been treated for a neurodevelopmental disorder diagnosis during childhood than participants reporting a heterosexual identity. Sexual minority participants overall and women in particular were more likely to have been treated for an internalizing disorder diagnosis at an early age compared with heterosexual participants, with this disparity starting at age 13. The sexual orientation disparity in likelihood of treatment for a neurodevelopmental disorder diagnosis was particularly elevated among bisexual/pansexual women with this disparity starting in early/middle adolescence.</p><p><strong>Conclusion: </strong>This population-based study linked to physician-assessed mental health diagnoses during childhood and adolescence identifies the age at which sexual orientation differences in treatment for common mental disorders emerge. The early emergence of this disparity suggests a potential benefit of interventions that facilitate social belonging for all youth.</p>","PeriodicalId":17186,"journal":{"name":"Journal of the American Academy of Child and Adolescent Psychiatry","volume":null,"pages":null},"PeriodicalIF":9.2,"publicationDate":"2024-08-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141889584","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Community Health Workers: Bridge to Pediatric Mental Health Equity. 社区保健工作者:通向儿科心理健康平等的桥梁。
IF 9.2 1区 医学 Q1 PEDIATRICS Pub Date : 2024-08-02 DOI: 10.1016/j.jaac.2024.07.917
Eve-Lynn Nelson, Stephanie Punt, Robert Stiles, Sharon E Cain

We currently face a national crisis1 in youth mental health and well-being and significant child behavioral health inequities. There is a growing recognition among health care institutions, policymakers, researchers, and communities that major health problems of our time, including this crisis, must be confronted by addressing the underlying "causes of the causes,"2 or social determinants of health. Social determinants of health3 are defined by the US Centers for Disease Control and Prevention as the conditions in which people live, learn, work, play, worship, and age and highlight the role that power and privilege occupy in shaping societal access to these resources. Social determinants of mental health (SDoMH) encompass the same conditions of social determinants of health, with the addition of the stigma often associated with mental health and substance use disorders. SDoMH focus on the social/environmental factors that place certain groups at increased risk for mental health concerns and worsening outcomes for individuals who already have mental health concerns.4 Addressing SDoMH is a key strategy to toward Healthy People 20305 goals and "the attainment of the highest level of health for all people."

目前,我们面临着全国性的青少年心理健康和福祉危机,以及严重的儿童行为健康不平等问题。解决社会决定因素是实现健康公平的首要途径。心理健康的社会决定因素(SDoMH)影响着整个心理健康服务体系中的每一位儿童,而社会阶层、种族、性别、性取向、身体能力、民族血统、智力或精神能力以及其他群体类别和群体类别组合的歧视则造成了不平等。虽然临床医生对推进 SDoMH 资源和社会正义的热情、智慧和支持至关重要,但对于已经不堪临床重负的临床人员来说,驾驭瞬息万变的社区资源并为个体患者量身定制策略可能是一项艰巨的任务。我们以 Cotton 和 Shim(2022 年)的呼吁为基础,呼吁临床医生采取行动,满足整个公共卫生框架/金字塔中的 SDoMH 需求。在这种传统的临床医生驱动模式的基础上,我们提出了一种社区团队模式的补充方法。它增加了一个新的团队成员--社区保健员 (CHW)。社区保健员具有深厚的社区联系、社区关系和信任,能够围绕未满足的 SDoMH 需求,为家庭驱动的优先事项提供支持。他们帮助家庭驾驭不断变化的当地资源、联系人和流程,以满足 SDoMH 需求和社会变革。我们分享了不同地域(城市和农村)、不同环境(诊所、学校、教堂)和不同临床服务提供方式(传统的面对面服务和远程医疗)的社区团队案例,旨在改善儿童的生物心理社会成果。
{"title":"Community Health Workers: Bridge to Pediatric Mental Health Equity.","authors":"Eve-Lynn Nelson, Stephanie Punt, Robert Stiles, Sharon E Cain","doi":"10.1016/j.jaac.2024.07.917","DOIUrl":"10.1016/j.jaac.2024.07.917","url":null,"abstract":"<p><p>We currently face a national crisis<sup>1</sup> in youth mental health and well-being and significant child behavioral health inequities. There is a growing recognition among health care institutions, policymakers, researchers, and communities that major health problems of our time, including this crisis, must be confronted by addressing the underlying \"causes of the causes,\"<sup>2</sup> or social determinants of health. Social determinants of health<sup>3</sup> are defined by the US Centers for Disease Control and Prevention as the conditions in which people live, learn, work, play, worship, and age and highlight the role that power and privilege occupy in shaping societal access to these resources. Social determinants of mental health (SDoMH) encompass the same conditions of social determinants of health, with the addition of the stigma often associated with mental health and substance use disorders. SDoMH focus on the social/environmental factors that place certain groups at increased risk for mental health concerns and worsening outcomes for individuals who already have mental health concerns.<sup>4</sup> Addressing SDoMH is a key strategy to toward Healthy People 2030<sup>5</sup> goals and \"the attainment of the highest level of health for all people.\"</p>","PeriodicalId":17186,"journal":{"name":"Journal of the American Academy of Child and Adolescent Psychiatry","volume":null,"pages":null},"PeriodicalIF":9.2,"publicationDate":"2024-08-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141889583","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Exposure to Racism on Social Media and Acute Suicide Risk in Adolescents of Color: Results From an Intensive Monitoring Study 社交媒体上的种族主义暴露与有色人种青少年的急性自杀风险:一项强化监测研究的结果。
IF 9.2 1区 医学 Q1 PEDIATRICS Pub Date : 2024-08-01 DOI: 10.1016/j.jaac.2024.03.009
{"title":"Exposure to Racism on Social Media and Acute Suicide Risk in Adolescents of Color: Results From an Intensive Monitoring Study","authors":"","doi":"10.1016/j.jaac.2024.03.009","DOIUrl":"10.1016/j.jaac.2024.03.009","url":null,"abstract":"","PeriodicalId":17186,"journal":{"name":"Journal of the American Academy of Child and Adolescent Psychiatry","volume":null,"pages":null},"PeriodicalIF":9.2,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140306067","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of the American Academy of Child and Adolescent Psychiatry
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1